Skip to search formSkip to main contentSkip to account menu

CV 2619

Known as: CV-2619 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1986
1986
To investigate the possible action-sites of a cerebral metabolism activator, idebenone (CV-2619), its distribution in the brain… 
1985
1985
After oral administration of 14C-labeled idebenone (14C-CV-2619) to rats, the plasma 14C level reached a plateau at 15 min, which… 
Highly Cited
1985
Highly Cited
1985
Effect of idebenone (CV-2619) on memory impairment was studied in rats with cerebral embolization. The cerebral embolization… 
1985
1985
The effects of 6-(10-hydroxydecyl)-2,3-dimethoxy-5-methyl-1,4-benzoquinone (idebenone, CV-2619) on the contents, turnover… 
1985
1985
Metabolic studies of idebenone (CV-2619), a new cerebral metabolism improving agent, in the rat and dog by thin-layer… 
1985
1985
The effect of 6-(10-hydroxydecyl)-2, 3-dimethoxy-5-methyl-1, 4-benzoquinone (idebenone, CV-2619) on brightness discrimination… 
Highly Cited
1984
Highly Cited
1984
An experimental model of amnesia induced by cerebral ischemia after one-trial passive avoidance learning was established to test… 
Highly Cited
1984
Highly Cited
1984
The concentrations of acetylcholine (Ach) and choline in various brain regions of rats with and without cerebral ischemia and the… 
1984
1984
Improvement of energy metabolism in ischemic cerebral tissue benefits the therapy of occlusive cerebrovascular lesions. In the…